Yi Ouyang

1.0k total citations
33 papers, 784 citations indexed

About

Yi Ouyang is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yi Ouyang has authored 33 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Yi Ouyang's work include Vitamin D Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Yi Ouyang is often cited by papers focused on Vitamin D Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Yi Ouyang collaborates with scholars based in China, United States and Germany. Yi Ouyang's co-authors include Nancy Q. Liu, Venu Lagishetty, Martin Hewison, Alexander V. Misharin, Thomas S. Lisse, Sandra M. McLachlan, John S. Adams, Rene F. Chun, Ozlem Equils and Amber Kaplan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Yi Ouyang

30 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Ouyang China 15 298 187 142 121 105 33 784
Shujun Song China 18 218 0.7× 269 1.4× 80 0.6× 48 0.4× 104 1.0× 32 939
Akihiro Fujino Japan 19 100 0.3× 204 1.1× 88 0.6× 29 0.2× 156 1.5× 88 1.1k
Cornelia Blume Germany 20 37 0.1× 213 1.1× 185 1.3× 59 0.5× 123 1.2× 75 1.3k
Dan Lü China 19 64 0.2× 388 2.1× 55 0.4× 81 0.7× 33 0.3× 61 979
Muzaffer Çaydere Türkiye 18 84 0.3× 87 0.5× 47 0.3× 78 0.6× 77 0.7× 85 957
Jiedong Wang China 14 52 0.2× 103 0.6× 133 0.9× 101 0.8× 65 0.6× 40 633
Elenice Deffune Brazil 19 58 0.2× 270 1.4× 43 0.3× 48 0.4× 24 0.2× 87 1.2k
Jing Liang China 16 64 0.2× 207 1.1× 75 0.5× 30 0.2× 32 0.3× 74 967
Y. Wang United States 18 32 0.1× 124 0.7× 251 1.8× 344 2.8× 65 0.6× 27 843

Countries citing papers authored by Yi Ouyang

Since Specialization
Citations

This map shows the geographic impact of Yi Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ouyang more than expected).

Fields of papers citing papers by Yi Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ouyang. The network helps show where Yi Ouyang may publish in the future.

Co-authorship network of co-authors of Yi Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ouyang. A scholar is included among the top collaborators of Yi Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ouyang. Yi Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Xiaodan, Yi Ouyang, Xueping Zheng, et al.. (2025). RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer. Cell Death and Disease. 16(1). 130–130.
4.
Li, Wenyun, et al.. (2025). HPV vaccine awareness and acceptance among rural women in Xinjiang, China. Scientific Reports. 15(1). 25515–25515. 1 indexed citations
5.
Rezhake, Remila, Yi Ouyang, Wenyun Li, et al.. (2025). Evaluation of the multiple HPV-based “screen and triage” algorithms in real-world settings of rural China. Cancer Biology and Medicine. 22(9). 1053–1067. 1 indexed citations
6.
Ouyang, Yi & Miaomiao Dai. (2024). Anxiety disorders and adhesive capsulitis: a bidirectional Mendelian randomization study. Frontiers in Immunology. 14. 1297477–1297477. 1 indexed citations
7.
Ouyang, Yi & Miaomiao Dai. (2023). Screening for genes, miRNAs and transcription factors of adipogenic differentiation and dedifferentiation of mesenchymal stem cells. Journal of Orthopaedic Surgery and Research. 18(1). 46–46. 7 indexed citations
8.
Huang, Xiaodan, Bei-Bei Xiao, Yi Ouyang, et al.. (2023). Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer. Cell Death and Differentiation. 31(1). 78–89. 25 indexed citations
9.
Li, Lin, Long Bai, Huan Lin, et al.. (2021). Multiomics analysis of tumor mutational burden across cancer types. Computational and Structural Biotechnology Journal. 19. 5637–5646. 19 indexed citations
10.
Liu, Jing, Tao Li, Kai Sen Tan, et al.. (2021). Mucus composition abnormalities in sinonasal mucosa of chronic rhinosinusitis with and without nasal polyps. Inflammation. 44(5). 1937–1948. 10 indexed citations
11.
Chen, Fo‐Ping, et al.. (2021). Circulating Epstein–Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma. European Journal of Cancer. 151. 63–71. 21 indexed citations
12.
Zhong, Wenlong, Meng Yang, Sida Cheng, et al.. (2021). Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma. Cancer Science. 113(3). 852–863. 2 indexed citations
13.
Lin, Yanzhu, et al.. (2019). Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma. Frontiers in Oncology. 9. 278–278. 3 indexed citations
14.
Hirschfeld, Marc, Yi Ouyang, Markus Jaeger, et al.. (2015). HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer. BMC Cancer. 15(1). 86–86. 25 indexed citations
15.
He, Fupo, Yan Chen, Jiyan Li, et al.. (2014). Improving bone repair of femoral and radial defects in rabbit by incorporating PRP into PLGA/CPC composite scaffold with unidirectional pore structure. Journal of Biomedical Materials Research Part A. 103(4). 1312–1324. 48 indexed citations
16.
Jadus, Martin R., Ahmed Aref, Neil Hoa, et al.. (2014). HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma. OncoTargets and Therapy. 7. 1061–1061. 13 indexed citations
17.
Reddy, Swapna, et al.. (2012). Colon MALT Lymphoma in a Patient with Multiple Endocrine Neoplasia Type I. The American Journal of Gastroenterology. 107. S479–S479. 1 indexed citations
18.
Chai, Jianyuan, et al.. (2012). CCN1 Induces β-Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin α11. PubMed. 2012. 1–10. 12 indexed citations
19.
Lagishetty, Venu, Alexander V. Misharin, Nancy Q. Liu, et al.. (2010). Vitamin D Deficiency in Mice Impairs Colonic Antibacterial Activity and Predisposes to Colitis. Endocrinology. 151(6). 2423–2432. 205 indexed citations
20.
Ouyang, Yi, Axel zur Hausen, Marzenna Orlowska‐Volk, et al.. (2010). Expression levels of hnRNP G and hTra2‐beta1 correlate with opposite outcomes in endometrial cancer biology. International Journal of Cancer. 128(9). 2010–2019. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026